A Scalable Approach Reveals Functional Responses of iPSC Cardiomyocyte 3D Spheroids.


Journal

SLAS discovery : advancing life sciences R & D
ISSN: 2472-5560
Titre abrégé: SLAS Discov
Pays: United States
ID NLM: 101697563

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 8 12 2020
medline: 1 3 2022
entrez: 7 12 2020
Statut: ppublish

Résumé

Cardiomyocytes (CMs) derived from induced pluripotent stem cells (iPSCs) provide an in vitro model of the human myocardium. Complex 3D scaffolded culture methods improve the phenotypical maturity of iPSC-CMs, although typically at the expense of throughput. We have developed a novel, scalable approach that enables the use of iPSC-CM 3D spheroid models in a label-free readout system in a standard 96-well plate-based format. Spheroids were accurately positioned onto recording electrodes using a magnetic gold-iron oxide nanoparticle approach. Remarkably, both contractility (impedance) and extracellular field potentials (EFPs) could be detected from the actively beating spheroids over long durations and after automated dosing with pharmacological agents. The effects on these parameters of factors, such as co-culture (including human primary cardiac fibroblasts), extracellular buffer composition, and electrical pacing, were investigated. Beat amplitudes were increased greater than 15-fold by co-culture with fibroblasts. Optimization of extracellular Ca

Identifiants

pubmed: 33283596
doi: 10.1177/2472555220975332
pii: S2472-5552(22)06690-4
doi:

Substances chimiques

Anti-Arrhythmia Agents 0
Barium Compounds 0
Chlorides 0
Ferric Compounds 0
Piperidines 0
Pyridines 0
barium chloride 0VK51DA1T2
E 4031 113558-89-7
ferric oxide 1K09F3G675
Gold 7440-57-5
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

352-363

Auteurs

Matthew P Burnham (MP)

Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Alderley Park, UK.
Medicines Discovery Catapult, Alderley Edge, Cheshire, UK.

Rachel Harvey (R)

Imperial College London, London, UK.

Rebecca Sargeant (R)

Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, Cambridgeshire, UK.

Niels Fertig (N)

Nanion Technologies GmbH, München, Bayern, Germany.

Malcolm Haddrick (M)

Medicines Discovery Catapult, Alderley Edge, Cheshire, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH